LONZA GROUP AG |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 527.8 CHF | +2.72% |
|
+4.97% | +49.22% |
| 18/04 | Global markets live: DocMorris, Microsoft, Oracle, Micron, Netflix... |  |
| 18/04 | Lonza Finance Launches EUR1 Billion 12-Year Euro Bond | DJ |
Chart calendar Lonza Group AG
7a.gSEQ3zfMFSqUIob_RdCkv8Xn9Stw4-6mFyGy95fYc0M.5VdEjmGhI1vCcc2NC5PwiY_UjBxEt4zhZnLiucfuIwLWckOUfPR_RPxt8Q~61b9f6fe4c336ea83532ba035fe746de
Upcoming events on Lonza Group AG
Past events on Lonza Group AG
| 26/03/2024 08:30 pm | Business Update Call |
| 20/03/2024 06:30 pm | Acquisition of Large-Scale Biologics Site in Vacaville from Roche by Lonza Call |
| 26/01/2024 06:30 pm | Q4 2023 Earnings Call |
| 26/01/2024 | Q4 2023 Earnings Release |
| 10/01/2024 03:00 am | JP Morgan Healthcare Conference |
| 04/01/2024 | Shareholders Meeting |
| 29/11/2023 | Nordic Life Sciences Day |
| 17/10/2023 01:00 pm | Capital Markets Day |
| 21/07/2023 05:30 pm | Q2 2023 Earnings Call |
| 21/07/2023 10:30 am | Q2 2023 Earnings Release |
| 09/05/2023 | Ex-dividend day for final dividend |
| 09/05/2023 | Ex-dividend day for Distribution from share premium account |
| 05/05/2023 01:30 pm | Annual General Meeting |
| 25/01/2023 06:30 pm | FY 2022 Earnings Call |
| 25/01/2023 | FY 2022 Earnings Release |
| 12/01/2023 12:00 am | JP Morgan Healthcare Conference |
| 28/09/2022 | Citi European HC Bus Tour |
| 15/09/2022 | Roadshow |
| 14/09/2022 | Roadshow |
| 02/09/2022 | Roadshow |
Past dividends on Lonza Group AG
| 09/05/2023 | Annual 1.75 CHF |
| 09/05/2023 | 1.75 CHF |
| 09/05/2022 | Annual 1.5 CHF |
| 09/05/2022 | 1.5 CHF |
| 10/05/2021 | 1.5 CHF |
| 10/05/2021 | Annual 1.5 CHF |
| 30/04/2020 | 1.375 CHF |
| 30/04/2020 | Annual 1.375 CHF |
| 24/04/2019 | 2.75 CHF |
| 08/05/2018 | 2.75 CHF |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million CHF | Released Forecast Spread | 5 920 5 897 0.4% | 6 185 6 161 0.39% | 5 409 5 187 4.28% | 6 223 6 189 0.55% | 6 717 6 512 3.14% | 6 643 |
|
EBITDA Million CHF | Released Forecast Spread | 1 624 1 615 0.57% | 1 728 1 696 1.91% | 1 665 1 654 0.66% | 1 995 1 936 3.03% | 1 999 1 899 5.26% | 1 863 |
|
EBIT Million CHF | Released Forecast Spread | 1 249 1 218 2.58% | 1 358 1 310 3.65% | 1 151 1 184 -2.79% | 1 397 1 372 1.85% | 939 1 263 -25.66% | 1 152 |
|
Earnings before Tax (EBT) Million CHF | Released Forecast Spread | 849 885 -4.04% | 986 981 0.51% | 760 847 -10.23% | 1 448 1 194 21.26% | 790 1 140 -30.71% | 1 073 |
|
Net income Million CHF | Released Forecast Spread | 645 720 -10.44% | 869 844 2.92% | 2 944 1 376 113.89% | 1 215 1 046 16.18% | 654 944 -30.7% | 904 |
|
EPS CHF | Released Forecast Spread | 8,65 9,68 -10.66% | 11,6 11,6 0.61% | 39,5 18,9 108.65% | 16,3 14,1 16.05% | 8,88 12,8 -30.77% | 12,4 |
| Announcement Date | 21/01/20 | 27/01/21 | 26/01/22 | 25/01/23 | 26/01/24 | - |
Quarterly results
| Fiscal Period | December | 2019 S2 | 2020 S1 | 2020 S2 | 2021 S1 | 2021 S2 | 2022 S1 | 2022 S2 | 2023 S1 | 2023 S2 | 2024 S1 | 2024 S2 | 2025 S1 | 2025 S2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million CHF | Released Forecast Spread | 2 944 2 907 1.26% | 3 074 3 080 -0.2% | 3 111 3 086 0.8% | 2 542 2 474 2.74% | 2 867 2 650 8.18% | 2 982 2 965 0.58% | 3 241 3 201 1.25% | 3 078 3 168 -2.85% | 3 639 3 440 5.77% | 3 135 | 3 454 | 3 466 | 3 779 |
|
EBITDA Million CHF | Released Forecast Spread | 796 783 1.66% | 893 848 5.36% | 835 813 2.72% | 847 778 8.91% | 818 813 0.63% | 987 930 6.11% | 1 008 984 2.49% | 922 933 -1.23% | 1 077 988 8.98% | 838 | 976 | 985 | 1 135 |
|
EBIT Million CHF | Released Forecast Spread | 606 581 4.26% | 706 637 10.76% | 652 608 7.33% | 606 607 -0.12% | 545 613 -11.14% | 698 680 2.59% | 699 703 -0.6% | 563 619 -9.09% | 376 670 -43.86% | 527 | 644 | ||
|
Earnings before Tax (EBT) Million CHF | Released Forecast Spread | 407 424 -4.03% | 564 479 17.87% | 422 467 -9.6% | 296 476 -37.81% | 464 525 -11.64% | 594 637 -6.81% | 854 667 28% | 486 556 -12.62% | 304 608 -50.02% | 470 | 602 | ||
|
Net income Million CHF | Released Forecast Spread | 346 339 2.19% | 477 399 19.65% | 392 391 0.17% | 319 414 -23.01% | 2 625 2 466 6.45% | 492 539 -8.74% | 723 537 34.55% | 410 465 -11.88% | 244 511 -52.26% | 389 | 496 | ||
|
EPS CHF | Released Forecast Spread | 4,64 4,70 -1.17% | 6,39 5,35 19.38% | 5,24 5,16 1.58% | 4,28 5,50 -22.13% | 35,2 33,1 6.56% | 6,61 7,12 -7.21% | 9,73 7,19 35.28% | 5,54 6,21 -10.79% | 3,34 6,95 -51.93% | 5,31 | 6,78 | ||
| Announcement Date | 21/01/20 | 24/07/20 | 27/01/21 | 23/07/21 | 26/01/22 | 22/07/22 | 25/01/23 | 21/07/23 | 26/01/24 | - | - | - | - |
More events
Past sector events for Lonza Group AG
| Today | GEMPHARMATECH CO., LTD.: Q1 2024 Earnings Release |
| Today | GEMPHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 26/04/2024 10:30 am | BB BIOTECH AG: Q1 2024 Earnings Release |
| 26/04/2024 | BIDE PHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 26/04/2024 | PHARMARESOURCES (SHANGHAI) CO., LTD.: Q1 2024 Earnings Release |
| 26/04/2024 | HINOVA PHARMACEUTICALS INC.: Q1 2024 Earnings Release (Projected) |
| 26/04/2024 | BEIJING SUN-NOVO PHARMACEUTICAL RESEARCH CO., LTD.: Q4 2023 Earnings Release |
| 26/04/2024 | CHEMPARTNER PHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 25/04/2024 04:30 pm | MORPHIC HOLDING, INC.: Q1 2024 Earnings Release |
| 25/04/2024 11:30 am | PURETECH HEALTH PLC: Q4 2023 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- LONN Stock
- Calendar Lonza Group AG
